Skip to content

Effect of pre stimulation to magnetic stimulation in treatment of old age depression and associated brain wave changes

Effect of priming on adjunctive repetitive trans cranial magnetic stimulation in the treatment of late life depression, and associated quantitative EEG changes: A prospective randomised sham controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/08/027230
Enrollment
40
Registered
2020-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features Health Condition 2: F331- Major depressive disorder, recurrent, moderate Health Condition 3: F321- Major depressive disorder, singleepisode, moderate Health Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

Intervention1: Active Priming to Adjunctive rTMS: 6Hz rTMS at 80%RMT over right DLPFC for 10 minutes followed by 100% RMT 1 Hz rTMS over right DLPFC for 21 minutes Control Intervention1: Sham Priming

Sponsors

King Georges Medical University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Right handed persons Willing to give written informed consent Fulfilling the diagnoses as mentioned according to ICD 10 (F32.1/33.1 and F32.2/F33.2)

Exclusion criteria

Exclusion criteria: Any co morbid alcohol or other substance dependence except for caffeine and nicotine Presence of psychosis History of epilepsy/seizure Comorbidity of severe surgical or medical illnesses not letting the patient cooperate for rTMS Patients with cardiac pacemaker or other metal parts in body Patients who have received ECT in the past 6 months

Design outcomes

Primary

MeasureTime frame
Primary objective is to compare the effect of theta priming vis a vis a vis no priming on adjunctive 1 Hz rTMS over right DLPFC in treatment of late life depression. Assessments using HAM D, HAM A, GDS, Somatic symptoms scale 8, HMSE and CGI-I Timepoint: From baseline to end of week 1, 2 and 4 after initiation of intervention

Secondary

MeasureTime frame
Secondary objective is to study the associated quantitative EEG changes in frontal beta and theta waves in the two groupsTimepoint: Before, at baseline and after treatment, at the end of 2 weeks

Countries

India

Contacts

Public ContactVidya K L

King Georges Medical University, Lucknow

dr.vidyakl@gmail.com7631004167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026